
www.finabio.net
Andrew Lees博士于2006年创建了Fina Bio公司,以帮助新兴市场疫苗制造商学会为疫苗生产价格合理的蛋白质多糖偶联物。Fina Bio公司现在是生物技术和疫苗行业联合疫苗实验室和咨询服务的主要供应商。Fina Bio公司位于马里兰州生物技术走廊的中心,毗邻美国国立卫生研究院(NIH)、美国食品和药物管理局(FDA)以及许多生物制药公司。Fina Bio公司有一个设备齐全的实验室,用于分子生物学和蛋白质表达、偶联和偶联疫苗的鉴定。Fina Bio公司的科学家与约翰霍普金斯大学和马里兰大。
FinaBio Ready-to-Conjugate 蛋白
Ready-to-Conjugate Proteins
即型共轭蛋白质类促进结合的新产品
Fina Biosolutions Ready-to-Conjugatecarrier 蛋白通过提供预活化的载体蛋白促进免疫结合物的合成。我们的 Ready-to-Conjugatecarrier 蛋白包括 EcoCRM(FinaBio 的 CRM),以及破伤风毒素重链片段 C (TTHc) 和牛血清白蛋白 (BSA)。这些蛋白用马来酰亚胺或溴乙酸预先标记,并准备与巯基抗原偶联,如半胱氨酸肽和巯基标记的寡糖和多糖。免疫结合物可以很容易地通过 Ready-to-ConjugateCRM-马来酰亚胺和 CRM-溴乙酸盐进行制备和表征。马来酰亚胺-crm 和溴乙酰基-crm 与巯基抗原的反应方案如图 1 所示。将 N-末端半胱氨酸肽 (MW~1.5 kDa) 分别偶联,并通过 SDS PAGE 进行分析。发现各结合物的肽上样水平相似
FinaBio 提供 Ready-to-Conjugate 蛋白,包括 EcoCRM (CRM)、破伤风毒素重链片段 C (TTHc) 和牛血清白蛋白。这些蛋白用马来酰亚胺或溴乙酸预先标记。相关产物包括未标记的 crm 和 TTHc,以及这些蛋白的抗体。Fina Biosolutions 还提供多肽、蛋白质、寡糖和多糖的偶联服务
Fina Biosolutions, LLC mission is to help manufacture affordable conjugate vaccines for emerging markets. We are a global provider of conjugate vaccine laboratory and consulting services for the Biotech and Vaccine industry, with core expertise in conjugation chemistry, bioconjugation and conjugate vaccines
共轭技术专长 Fina Biosolutions, LLC的使命是为新兴市场制造价格合理的共轭疫苗。我们是生物技术和疫苗行业共轭疫苗实验室服务和咨询服务的全球提供商,在共轭化学、生物共轭和共轭疫苗领域拥有核心专长。
Fina Biosolutions’ Molecular Biology Group has developed an E. coli strain for producing carrier proteins.
Fina Biosolutions has applied its expertise in polysaccharide conjugation to the production and characterization of functionalized dextrans and related products. Our products include:
功能化右旋糖酐 Fina Biosolutions运用其在多糖共轭方面的专业知识,生产和表征功能化右旋糖酐及相关产品。我们的产品包括:氨基和羧基右旋糖酐、荧光右旋糖酐以及独特的单功能化和多功能化右旋糖酐。
热卖产品
| 货号 | 产品名称 | 规格 | 品牌/生产厂家 |
|---|---|---|---|
| AD10x10 | 10 kDa AD(MW KDa)x(NH2) | 500mg | finabio |
| AD2000x1000-100mg | 2000 kDa AD(MW KDa)x(NH2) | 100mg | finabio |
| AD2000x1000-500mg | 2000 kDa AD(MW KDa)x(NH2) | 500mg | finabio |
| AD20x20 | 20 kDa AD(MW KDa)x(NH2) | 500mg | finabio |
| AD20x20-500mg | 20 kDa AD(MW KDa)x(NH2) | 500mg | finabio |
| AD40x20 | 40 kDa Amino Dextran | 100mg | finabio |
| AD40x20-500mg | 40 kDa Amino Dextran | 500mg | finabio |
| AD40x50 | 40 kDa Amino Dextran | 100mg | finabio |
| AD40x50-500mg | 40 kDa AD(MW KDa)x(NH2) | 500mg | finabio |
| AD500x100 | 500 kDa Amino Dextran | 100 mg | finabio |
| AD6x05 | 6 kDa AD(MW KDa)x(NH2) | 500mg | finabio |
| AD70x25 | 70 kDa amino dextrans | 500mg | finabio |
| AFic-400×100 | 100 Amines/400kDa Ficoll | 100 mg | finabio |
| Anti-IgDdextran(human) | Anti-IgD dextran(human) | 10ug | finabio |
| Anti-IgDdextran(mouse) | Anti-IgD dextran (mouse) | 10ug | finabio |
| Anti-IgM dextran (mouse) | Anti-IgM dextran (mouse) | 10ug | finabio |
| Anti-IgM dextran(human) | Antibody Dextran Conjugates | 10ug | finabio |
| CRM197 | CRM197 | 1mg | finabio |
| CRM197-10mg | Carrier proteins | 10mg | finabio |
| CRM197-1g | CRM197 | 1g | finabio |
| CRM197-1g-GMP | GMP grade CRM197 | 1g | finabio |
| CRM197-1mg | Carrier proteins | 1mg | finabio |
| CRM197-25mg | Carrier proteins | 25mg | finabio |
| CRM197-40mg | CRM197 | 40mg | finabio |
| CRM197-50mg | CRM197 | 50mg | finabio |
| CRM197-5mg | Carrier proteins | 5 mg | finabio |
| CRM197-mal | 活化好的crm197 | ea | finabio |
| CRM-maleimide | CRM-maleimide | 5mg | finabio |
| CRM-maleimide-1mg | CRM-maleimide | 1mg | finabio |
| FinaBio0001 | Anti-IgD dextran (mouse) | 10ug | finabio |
| Flu-dex70K-100mg | Fluorescein-dextran | 100mg | finabio |
| Flu-dex70K-25mg | Fluorescein-dextran | 25mg | finabio |
| MAL-DEX6-1.5 | High Ratio Maleimide Dextrans | 100 mg | finabio |
| SA-250kDadextran | Streptavidin dextran | 100ug | finabio |
| TMR-dex10K–25mg | TMR-Dextran | 25 mg | finabio |
| TMR-dex70K-100mg | TMR-dextran | 100mg | finabio |
| TMR-dex70K-25mg | TMR-dextran | 25mg | finabio |
| TNP-Ficoll-01-10mg | TNP-Ficoll(400) | 10mg | finabio |